Basic Information
| LncRNA/CircRNA Name | LCAL6 |
| Synonyms | BLACAT1, LINC00912, linc-UBC1, onco-lncRNA-30 |
| Region | GRCh38_1:205434886-205437879 |
| Ensemble | ENSG00000281406 |
| Refseq | NR_103783 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | lung adenocarcinoma |
| ICD-0-3 | C34 |
| Methods | qPCR, RNAi, Flow cytometry assay etc. |
| Sample | NSCLC tissues, cell lines (A549 and NCI-H1299) |
| Expression Pattern | up-regulated |
| Function Description | We found the lung cancer associated lncRNA 6 (LCAL6) was significantly unregulated and predicted survival in LUAD. Silence of LCAL6 inhibited LUAD tumor cell growth both in vitro and in vivo. |
| Pubmed ID | 26918601 |
| Year | 2016 |
| Title | Comprehensive analysis of lncRNA expression profiles and identification of functional lncRNAs in lung adenocarcinoma. |
External Links
| Links for LCAL6 | GenBank HGNC NONCODE |
| Links for lung adenocarcinoma | OMIM COSMIC |